GO ID |
Ontology |
GO Term |
Term Definition |
Proteins |
GO:0008543
|
BP
|
fibroblast growth factor receptor signaling pathway
|
The series of molecular signals generated as a consequence of a fibroblast growth factor receptor binding to one of its physiological ligands.
|
POLR2D,
FLRT2,
RBFOX2,
FGF18,
FGF19,
FGF2,
HNRNPA1,
UBC,
FGFR1,
GTF2F2,
POLR2E,
FGF7,
FGFR2,
ANOS1,
POLR2A,
PTBP1,
MAPK3,
MAPK1,
CTGF,
POLR2B,
FGF9,
TIA1,
HNRNPH1,
GTF2F1,
POLR2I,
IQGAP1,
HNRNPM,
POLR2J,
NDST1,
POLR2K,
FGF12,
POLR2G,
POLR2L,
RPS27A,
UBA52,
GRB2,
PTPN11,
NCBP1,
SETX,
SPRED1,
CEP57,
SHCBP1,
FRS2,
ESRP2,
FLRT3,
FLRT1,
KL
|
GO:0008544
|
BP
|
epidermis development
|
The process whose specific outcome is the progression of the epidermis over time, from its formation to the mature structure. The epidermis is the outer epithelial layer of an animal, it may be a single layer that produces an extracellular material (e.g. the cuticle of arthropods) or a complex stratified squamous epithelium, as in the case of many vertebrate species.
|
INSR,
KRT16,
STS,
PTHLH,
DSP,
ATP2A2,
FGF7,
CTGF,
S100A7,
SPRR2B,
KRT9,
ALDH3A2,
EMP1,
ELF3,
ATP2C1,
FABP5,
SATB1,
BNC1,
PLOD1,
KRT17,
PPARA,
GAB1,
UGCG,
LAMA3,
SPRR2G,
GRHL1,
SPRR3,
COL17A1
|
GO:0008582
|
BP
|
regulation of synaptic growth at neuromuscular junction
|
Any process that modulates the frequency, rate or extent of synaptic growth at neuromuscular junctions.
|
MUSK,
COLQ
|
GO:0008584
|
BP
|
male gonad development
|
The process whose specific outcome is the progression of the male gonad over time, from its formation to the mature structure.
|
TLR3,
BCL2L11,
SOX15,
NUPR1,
TLR5,
LHB,
ESR1,
INHA,
INSR,
ERCC1,
INHBA,
BCL2,
KIT,
SRD5A1,
WT1,
KITLG,
LHCGR,
RRM1,
FSHR,
HMGB2,
KDM5A,
SRD5A2,
HOXA10,
FGF9,
CTNNA1,
NUDT1,
TGFBR1,
WNT5A,
AKR1C3,
MSH2,
GATA4,
SOX9,
NASP,
STAR,
MMP14,
TNFSF10,
NR0B1,
SOX8,
TGFB2,
H3F3A,
HMGCS1,
PRDX4,
MAMLD1,
NCOA4,
ARID5B,
NCOA1,
AMHR2,
ASPM,
SFRP1,
GATA6,
WNT2B,
PITX2,
RNF38,
PATZ1,
AGO4,
BOK
|
GO:0008585
|
BP
|
female gonad development
|
The process whose specific outcome is the progression of the female gonad over time, from its formation to the mature structure.
|
IDH1,
FSHR,
BRCA2,
ARID5B,
AMHR2,
SFRP1,
PITX2
|
GO:0008588
|
BP
|
release of cytoplasmic sequestered NF-kappaB
|
The release of NF-kappaB from specific molecules in the cytoplasm to which it was bound, thereby allowing its translocation into the nucleus.
|
CD27,
TRIP6
|
GO:0008589
|
BP
|
regulation of smoothened signaling pathway
|
Any process that modulates the frequency, rate or extent of smoothened signaling.
|
GLI2,
FGFR2,
OTX2,
RORA,
GAS1,
PTCH1,
ZIC1,
CREBBP,
INTU
|
GO:0008593
|
BP
|
regulation of Notch signaling pathway
|
Any process that modulates the frequency, rate or extent of the Notch signaling pathway.
|
CD46,
IL6ST,
SYNJ2BP,
POSTN
|
GO:0008595
|
BP
|
anterior/posterior axis specification, embryo
|
The specification of the anterior/posterior axis of the embryo by the products of genes expressed maternally and genes expressed in the zygote.
|
TDGF1,
WNT5A,
FRS2
|
GO:0008608
|
BP
|
attachment of spindle microtubules to kinetochore
|
The process in which spindle microtubules become physically associated with the proteins making up the kinetochore complex.
|
NDC80,
ZNF207,
BUB3,
FAM175B,
SGOL1,
TEX14,
CASC5,
AURKB
|
GO:0008610
|
BP
|
lipid biosynthetic process
|
The chemical reactions and pathways resulting in the formation of lipids, compounds soluble in an organic solvent but not, or sparingly, in an aqueous solvent.
|
AGPS,
ACSL1,
SREBF1,
PRKAA2,
GPAT4,
ACSS2,
PRPF19
|
GO:0008611
|
BP
|
ether lipid biosynthetic process
|
The chemical reactions and pathways resulting in the formation of ether lipids, lipids that contain (normally) one lipid alcohol in ether linkage to one of the carbon atoms (normally C-1) of glycerol.
|
AGPS,
GNPAT
|
GO:0008612
|
BP
|
peptidyl-lysine modification to peptidyl-hypusine
|
The modification of peptidyl-lysine to form hypusine, peptidyl-N6-(4-amino-2-hydroxybutyl)-L-lysine.
|
DHPS,
EIF5A,
DOHH,
EIF5A2
|
GO:0008615
|
BP
|
pyridoxine biosynthetic process
|
The chemical reactions and pathways resulting in the formation of pyridoxine, 2-methyl-3-hydroxy-4,5-bis(hydroxymethyl)pyridine, one of the vitamin B6 compounds.
|
PSAT1
|
GO:0008616
|
BP
|
queuosine biosynthetic process
|
The chemical reactions and pathways resulting in the formation of queuosines, any of a series of nucleosides found in tRNA and having an additional pentenyl ring added via an NH group to the methyl group of 7-methylguanosine. The pentenyl ring may carry other substituents.
|
PDC,
PDCL,
PDCL3
|
GO:0008617
|
BP
|
guanosine metabolic process
|
The chemical reactions and pathways involving guanine, guanine riboside, a nucleoside with a wide species distribution.
|
DGUOK
|
GO:0008625
|
BP
|
extrinsic apoptotic signaling pathway via death domain receptors
|
A series of molecular signals in which a signal is conveyed from the cell surface to trigger the apoptotic death of a cell. The pathway starts with a ligand binding to a death domain receptor on the cell surface, and ends when the execution phase of apoptosis is triggered.
|
DDX3X,
TNFRSF10C,
NGF,
TNF,
BCL2,
FAS,
CD27,
PIK3R1,
DAPK1,
BID,
CRADD,
BAX,
FADD,
TRADD,
BAD,
MOAP1,
DDX47
|
GO:0008626
|
BP
|
granzyme-mediated apoptotic signaling pathway
|
A series of molecular signals induced by granzymes which triggers the apoptotic death of a cell. The pathway starts with reception of a granzyme signal, and ends when the execution phase of apoptosis is triggered. Granzymes are serine proteases that are secreted by cytotoxic T cells and natural killer cells to induce apoptosis in target cells.
|
UBE4B,
SRGN,
LAMP1,
BNIP3
|
GO:0008628
|
BP
|
hormone-mediated apoptotic signaling pathway
|
A series of molecular signals mediated by the detection of a hormone, and which triggers the apoptotic signaling pathway in a cell. The pathway starts with reception of a hormone signal, and ends when the execution phase of apoptosis is triggered.
|
PTH
|
GO:0008630
|
BP
|
intrinsic apoptotic signaling pathway in response to DNA damage
|
A series of molecular signals in which an intracellular signal is conveyed to trigger the apoptotic death of a cell. The pathway is induced by the detection of DNA damage, and ends when the execution phase of apoptosis is triggered.
|
BCL2L11,
TNF,
HMOX1,
BCL2,
TNFRSF1B,
XPA,
PIK3R1,
SFN,
BRCA1,
MLH1,
MSH6,
CASP9,
PRKDC,
E2F1,
BAX,
MCL1,
NFATC4,
BCL2L2,
BAD,
MOAP1,
FNIP2,
BOK
|
GO:0008631
|
BP
|
intrinsic apoptotic signaling pathway in response to oxidative stress
|
A series of molecular signals in which an intracellular signal is conveyed to trigger the apoptotic death of a cell. The pathway is induced in response to oxidative stress, a state often resulting from exposure to high levels of reactive oxygen species, and ends when the execution phase of apoptosis is triggered.
|
PRODH,
JAK2,
ARL6IP5,
GPX1,
BCL2,
PRKCD,
MELK,
PDK1,
CYP1B1,
MAP3K5,
STK24
|
GO:0008635
|
BP
|
activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c
|
Any process that initiates the activity of the inactive enzyme cysteine-type endopeptidase in the context of an apoptotic process and is mediated by cytochrome c.
|
CASP9,
CYCS,
BAX
|
GO:0008637
|
BP
|
apoptotic mitochondrial changes
|
The morphological and physiological alterations undergone by mitochondria during apoptosis.
|
HSPD1,
SLC25A4,
NDUFS1,
PPIF,
AKT1,
GCLC,
GCLM,
BID,
PPP2CB,
BAX,
MCL1,
AIFM2
|
GO:0008643
|
BP
|
carbohydrate transport
|
The directed movement of carbohydrate into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. Carbohydrates are any of a group of organic compounds based of the general formula Cx(H2O)y.
|
AKT2,
SLC35A1,
PEA15,
SLC35D2,
SLC5A11,
SLC35A5,
SLC35D1,
SLC35A3
|
GO:0008645
|
BP
|
hexose transport
|
The directed movement of hexose into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. Hexoses are any aldoses with a chain of six carbon atoms in the molecule.
|
SLC2A5
|
GO:0008652
|
BP
|
cellular amino acid biosynthetic process
|
The chemical reactions and pathways resulting in the formation of amino acids, organic acids containing one or more amino substituents.
|
GLS,
GOT2,
ASNS,
CBS,
ALDH18A1,
PYCRL,
GPT2
|
GO:0008654
|
BP
|
phospholipid biosynthetic process
|
The chemical reactions and pathways resulting in the formation of phospholipids, any lipid containing phosphoric acid as a mono- or diester.
|
FADS1,
PTDSS1,
PCYT1A,
PLA2G16,
PPARD,
LPCAT3,
MBOAT2,
SERINC5,
ABHD5,
LPGAT1,
MBOAT7,
PCYT2,
ISYNA1,
SERINC1,
AGPAT4,
AGPAT3,
PEMT,
PCYT1B
|
GO:0009048
|
BP
|
dosage compensation by inactivation of X chromosome
|
Compensating for the two-fold variation in X-chromosome:autosome ratios between sexes by a global inactivation of all, or most of, the genes on one of the X-chromosomes in the XX sex.
|
BRCA1,
EIF1
|
GO:0009051
|
BP
|
pentose-phosphate shunt, oxidative branch
|
The branch of the pentose-phosphate shunt which involves the oxidation of glucose 6-P and produces ribulose 5-P, reduced NADP+ and carbon dioxide (CO2).
|
G6PD,
PGD
|
GO:0009052
|
BP
|
pentose-phosphate shunt, non-oxidative branch
|
The branch of the pentose-phosphate shunt which does not involve oxidation reactions. It comprises a series of sugar phosphate interconversions, starting with ribulose 5-P and producing fructose 6-P and glyceraldehyde 3-P.
|
TKT,
TALDO1,
SHPK
|
GO:0009056
|
BP
|
catabolic process
|
The chemical reactions and pathways resulting in the breakdown of substances, including the breakdown of carbon compounds with the liberation of energy for use by the cell or organism.
|
TMEM150A,
PTER
|
GO:0009058
|
BP
|
biosynthetic process
|
The chemical reactions and pathways resulting in the formation of substances; typically the energy-requiring part of metabolism in which simpler substances are transformed into more complex ones.
|
ALDH1L1,
PBLD,
NDUFAF6,
ALDH1L2,
APMAP
|
GO:0009060
|
BP
|
aerobic respiration
|
The enzymatic release of energy from inorganic and organic compounds (especially carbohydrates and fats) which requires oxygen as the terminal electron acceptor.
|
PMPCB,
SLC25A14,
UQCRH,
UQCRB,
SDHB,
UQCRC2,
ADSL,
UQCRC1,
BLOC1S1,
MTFR1,
FXN,
ME3,
COX19,
COX20,
MTFR2,
SDHC,
CHCHD5,
PANK2,
METTL17,
UQCR10,
COX11
|
GO:0009062
|
BP
|
fatty acid catabolic process
|
The chemical reactions and pathways resulting in the breakdown of a fatty acid, any of the aliphatic monocarboxylic acids that can be liberated by hydrolysis from naturally occurring fats and oils. Fatty acids are predominantly straight-chain acids of 4 to 24 carbon atoms, which may be saturated or unsaturated; branched fatty acids and hydroxy fatty acids also occur, and very long chain acids of over 30 carbons are found in waxes.
|
PPARD,
ECH1,
LPIN1
|
GO:0009063
|
BP
|
cellular amino acid catabolic process
|
The chemical reactions and pathways resulting in the breakdown of amino acids, organic acids containing one or more amino substituents.
|
ENOSF1
|
GO:0009069
|
BP
|
serine family amino acid metabolic process
|
The chemical reactions and pathways involving amino acids of the serine family, comprising cysteine, glycine, homoserine, selenocysteine and serine.
|
MTHFD1
|
GO:0009070
|
BP
|
serine family amino acid biosynthetic process
|
The chemical reactions and pathways resulting in the formation of amino acids of the serine family, comprising cysteine, glycine, homoserine, selenocysteine and serine.
|
PHGDH,
MTHFD1
|
GO:0009071
|
BP
|
serine family amino acid catabolic process
|
The chemical reactions and pathways resulting in the breakdown of amino acids of the serine family, comprising cysteine, glycine, homoserine, selenocysteine and serine.
|
THNSL2
|
GO:0009072
|
BP
|
aromatic amino acid family metabolic process
|
The chemical reactions and pathways involving aromatic amino acid family, amino acids with aromatic ring (phenylalanine, tyrosine, tryptophan).
|
TPH2,
HPDL
|
GO:0009082
|
BP
|
branched-chain amino acid biosynthetic process
|
The chemical reactions and pathways resulting in the formation of amino acids containing a branched carbon skeleton, comprising isoleucine, leucine and valine.
|
BCAT1
|
GO:0009083
|
BP
|
branched-chain amino acid catabolic process
|
The chemical reactions and pathways resulting in the breakdown of amino acids containing a branched carbon skeleton, comprising isoleucine, leucine and valine.
|
DLD,
DBT,
BCKDHA,
BCKDHB,
HIBADH,
ACADSB,
BCAT1,
ALDH6A1,
AUH,
HIBCH,
PPM1K,
MCCC1,
HSD17B10,
MCCC2
|
GO:0009086
|
BP
|
methionine biosynthetic process
|
The chemical reactions and pathways resulting in the formation of methionine (2-amino-4-(methylthio)butanoic acid), a sulfur-containing, essential amino acid found in peptide linkage in proteins.
|
MTHFD1,
MTR,
MTHFD2L
|
GO:0009098
|
BP
|
leucine biosynthetic process
|
The chemical reactions and pathways resulting in the formation of leucine, 2-amino-4-methylpentanoic acid.
|
BCAT1
|
GO:0009099
|
BP
|
valine biosynthetic process
|
The chemical reactions and pathways resulting in the formation of valine, 2-amino-3-methylbutanoic acid.
|
BCAT1
|
GO:0009100
|
BP
|
glycoprotein metabolic process
|
The chemical reactions and pathways involving glycoproteins, any protein that contains covalently bound glycose (i.e. monosaccharide) residues; the glycose occurs most commonly as oligosaccharide or fairly small polysaccharide but occasionally as monosaccharide.
|
PCSK6,
ST8SIA6,
ERP44
|
GO:0009101
|
BP
|
glycoprotein biosynthetic process
|
The chemical reactions and pathways resulting in the formation of glycoproteins, any protein that contains covalently bound glycose (i.e. monosaccharide) residues; the glycose occurs most commonly as oligosaccharide or fairly small polysaccharide but occasionally as monosaccharide.
|
LARGE
|
GO:0009106
|
BP
|
lipoate metabolic process
|
The chemical reactions and pathways involving lipoate, 1,2-dithiolane-3-pentanoate, the anion derived from lipoic acid.
|
DLD
|
GO:0009108
|
BP
|
coenzyme biosynthetic process
|
The chemical reactions and pathways resulting in the formation of coenzymes, any of various nonprotein organic cofactors that are required, in addition to an enzyme and a substrate, for an enzymatic reaction to proceed.
|
SLC25A16,
COASY,
PANK2
|
GO:0009113
|
BP
|
purine nucleobase biosynthetic process
|
The chemical reactions and pathways resulting in the formation of purine nucleobases, one of the two classes of nitrogen-containing ring compounds found in DNA and RNA, which include adenine and guanine.
|
GART,
PAICS,
SHMT1,
GMPS,
PPAT
|
GO:0009115
|
BP
|
xanthine catabolic process
|
The chemical reactions and pathways resulting in the breakdown of xanthine, 2,6-dihydroxypurine, a purine formed in the metabolic breakdown of guanine but not present in nucleic acids.
|
XDH,
AOX1
|
GO:0009116
|
BP
|
nucleoside metabolic process
|
The chemical reactions and pathways involving a nucleoside, a nucleobase linked to either beta-D-ribofuranose (a ribonucleoside) or 2-deoxy-beta-D-ribofuranose, (a deoxyribonucleoside), e.g. adenosine, guanosine, inosine, cytidine, uridine and deoxyadenosine, deoxyguanosine, deoxycytidine and thymidine (= deoxythymidine).
|
NME4,
UPP2,
PRPS2,
PPAT
|
GO:0009117
|
BP
|
nucleotide metabolic process
|
The chemical reactions and pathways involving a nucleotide, a nucleoside that is esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the glycose moiety; may be mono-, di- or triphosphate; this definition includes cyclic nucleotides (nucleoside cyclic phosphates).
|
ACPP,
FHIT,
SMARCAD1,
NUDT5,
REXO2
|
GO:0009132
|
BP
|
nucleoside diphosphate metabolic process
|
The chemical reactions and pathways involving a nucleoside diphosphate, a compound consisting of a nucleobase linked to a deoxyribose or ribose sugar esterified with diphosphate on the sugar.
|
NUDT7
|
GO:0009134
|
BP
|
nucleoside diphosphate catabolic process
|
The chemical reactions and pathways resulting in the breakdown of a nucleoside diphosphate, a compound consisting of a nucleobase linked to a deoxyribose or ribose sugar esterified with diphosphate on the sugar.
|
ENTPD3
|
GO:0009142
|
BP
|
nucleoside triphosphate biosynthetic process
|
The chemical reactions and pathways resulting in the formation of a nucleoside triphosphate, a compound consisting of a nucleobase linked to a deoxyribose or ribose sugar esterified with triphosphate on the sugar.
|
NME4,
AK1,
NME1,
NME2,
AK4,
CMPK1,
SUCLG1,
CMPK2,
AK8
|
GO:0009143
|
BP
|
nucleoside triphosphate catabolic process
|
The chemical reactions and pathways resulting in the breakdown of a nucleoside triphosphate, a compound consisting of a nucleobase linked to a deoxyribose or ribose sugar esterified with triphosphate on the sugar.
|
ENPP3,
ENTPD3,
ENPP1,
DCTPP1
|
GO:0009154
|
BP
|
purine ribonucleotide catabolic process
|
The chemical reactions and pathways resulting in the breakdown of a purine ribonucleotide, a compound consisting of ribonucleoside (a purine base linked to a ribose sugar) esterified with a phosphate group at either the 3' or 5'-hydroxyl group of the sugar.
|
HINT1
|
GO:0009156
|
BP
|
ribonucleoside monophosphate biosynthetic process
|
The chemical reactions and pathways resulting in the formation of a ribonucleoside monophosphate, a compound consisting of a nucleobase linked to a ribose sugar esterified with phosphate on the sugar.
|
PFAS,
PRPS2
|
GO:0009157
|
BP
|
deoxyribonucleoside monophosphate biosynthetic process
|
The chemical reactions and pathways resulting in the formation of a deoxyribonucleoside monophosphate, a compound consisting of a nucleobase linked to a deoxyribose sugar esterified with phosphate on the sugar.
|
TK2,
TK1,
TYMS,
DCK,
DGUOK
|
GO:0009165
|
BP
|
nucleotide biosynthetic process
|
The chemical reactions and pathways resulting in the formation of nucleotides, any nucleoside that is esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the glycose moiety; may be mono-, di- or triphosphate; this definition includes cyclic-nucleotides (nucleoside cyclic phosphates).
|
TK2,
DHFR,
TK1,
PRPS2,
DCK,
DCTD,
DGUOK,
AK8
|
GO:0009166
|
BP
|
nucleotide catabolic process
|
The chemical reactions and pathways resulting in the breakdown of nucleotides, any nucleoside that is esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the glycose moiety; may be mono-, di- or triphosphate; this definition includes cyclic-nucleotides (nucleoside cyclic phosphates).
|
UPP2,
UPP1
|
GO:0009168
|
BP
|
purine ribonucleoside monophosphate biosynthetic process
|
The chemical reactions and pathways resulting in the formation of purine ribonucleoside monophosphate, a compound consisting of a purine base linked to a ribose sugar esterified with phosphate on the sugar.
|
PFAS,
ADA,
GART,
PAICS,
ADSS,
ADSL,
GMPS,
PPAT,
ADSSL1
|
GO:0009186
|
BP
|
deoxyribonucleoside diphosphate metabolic process
|
The chemical reactions and pathways involving a deoxyribonucleoside diphosphate, a compound consisting of a nucleobase linked to a deoxyribose sugar esterified with diphosphate on the sugar.
|
RRM2
|
GO:0009187
|
BP
|
cyclic nucleotide metabolic process
|
The chemical reactions and pathways involving a cyclic nucleotide, a nucleotide in which the phosphate group is in diester linkage to two positions on the sugar residue.
|
PDE8A,
PDE8B
|
GO:0009191
|
BP
|
ribonucleoside diphosphate catabolic process
|
The chemical reactions and pathways resulting in the breakdown of a ribonucleoside diphosphate, a compound consisting of a nucleobase linked to a ribose sugar esterified with diphosphate on the sugar.
|
NUDT5
|
GO:0009214
|
BP
|
cyclic nucleotide catabolic process
|
The chemical reactions and pathways resulting in the breakdown of a cyclic nucleotide, a nucleotide in which the phosphate group is in diester linkage to two positions on the sugar residue.
|
CNP
|
GO:0009220
|
BP
|
pyrimidine ribonucleotide biosynthetic process
|
The chemical reactions and pathways resulting in the formation of a pyrimidine ribonucleotide, a compound consisting of nucleoside (a pyrimidine base linked to a ribose sugar) esterified with a phosphate group at either the 3' or 5'-hydroxyl group of the sugar.
|
CMPK1
|
GO:0009223
|
BP
|
pyrimidine deoxyribonucleotide catabolic process
|
The chemical reactions and pathways resulting in the breakdown of a pyrimidine deoxyribonucleotide, a compound consisting of nucleoside (a pyrimidine base linked to a deoxyribose sugar) esterified with a phosphate group at either the 3' or 5'-hydroxyl group of the sugar.
|
NT5C
|
GO:0009225
|
BP
|
nucleotide-sugar metabolic process
|
The cellular chemical reactions and pathways involving nucleotide-sugars, any nucleotide-carbohydrate in which the distal phosphoric residue of a nucleoside 5'-diphosphate is in glycosidic linkage with a monosaccharide or monosaccharide derivative.
|
TGDS
|
GO:0009229
|
BP
|
thiamine diphosphate biosynthetic process
|
The chemical reactions and pathways resulting in the formation of thiamine diphosphate, a derivative of thiamine (vitamin B1) which acts as a coenzyme in a range of processes including the Krebs cycle.
|
TPK1
|
GO:0009231
|
BP
|
riboflavin biosynthetic process
|
The chemical reactions and pathways resulting in the formation of riboflavin (vitamin B2), the precursor for the coenzymes flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD).
|
RFK
|
GO:0009235
|
BP
|
cobalamin metabolic process
|
The chemical reactions and pathways involving cobalamin (vitamin B12), a water-soluble vitamin characterized by possession of a corrin nucleus containing a cobalt atom.
|
ABCD4,
PRSS1,
ABCC1,
PRSS3,
CTRB2,
MMAA,
MMAB,
MTR,
CD320,
LMBRD1
|
GO:0009236
|
BP
|
cobalamin biosynthetic process
|
The chemical reactions and pathways resulting in the formation of cobalamin (vitamin B12), a water-soluble vitamin characterized by possession of a corrin nucleus containing a cobalt atom.
|
MMAA,
MMAB
|
GO:0009247
|
BP
|
glycolipid biosynthetic process
|
The chemical reactions and pathways resulting in the formation of glycolipid, a class of 1,2-di-O-acylglycerols joined at oxygen 3 by a glycosidic linkage to a carbohydrate part (usually a mono-, di- or tri-saccharide).
|
ST8SIA6,
B3GNT5
|
GO:0009249
|
BP
|
protein lipoylation
|
The addition of a lipoyl group to an amino acid residue in a protein.
|
NDUFAB1,
POP5,
LIPT1
|
GO:0009253
|
BP
|
peptidoglycan catabolic process
|
The chemical reactions and pathways resulting in the breakdown of peptidoglycans, any of a class of glycoconjugates found in bacterial cell walls.
|
LYG2,
PGLYRP2
|
GO:0009256
|
BP
|
10-formyltetrahydrofolate metabolic process
|
The chemical reactions and pathways involving 10-formyltetrahydrofolate, the formylated derivative of tetrahydrofolate.
|
MTHFD2L
|
GO:0009257
|
BP
|
10-formyltetrahydrofolate biosynthetic process
|
The chemical reactions and pathways resulting in the formation of 10-formyltetrahydrofolate, the formylated derivative of tetrahydrofolate.
|
MTHFD1
|
GO:0009258
|
BP
|
10-formyltetrahydrofolate catabolic process
|
The chemical reactions and pathways resulting in the breakdown of 10-formyltetrahydrofolate, the formylated derivative of tetrahydrofolate.
|
ALDH1L1,
ALDH1L2
|
GO:0009259
|
BP
|
ribonucleotide metabolic process
|
The chemical reactions and pathways involving a ribonucleotide, a compound consisting of ribonucleoside (a base linked to a ribose sugar) esterified with a phosphate group at either the 3' or 5'-hydroxyl group of the sugar.
|
RNASEH2B
|
GO:0009263
|
BP
|
deoxyribonucleotide biosynthetic process
|
The chemical reactions and pathways resulting in the formation of a deoxyribonucleotide, a compound consisting of deoxyribonucleoside (a base linked to a deoxyribose sugar) esterified with a phosphate group at either the 3' or 5'-hydroxyl group of the sugar.
|
RRM1,
RRM2
|
GO:0009264
|
BP
|
deoxyribonucleotide catabolic process
|
The chemical reactions and pathways resulting in the breakdown of a deoxyribonucleotide, a compound consisting of deoxyribonucleoside (a base linked to a deoxyribose sugar) esterified with a phosphate group at either the 3' or 5'-hydroxyl group of the sugar.
|
DERA
|
GO:0009266
|
BP
|
response to temperature stimulus
|
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a temperature stimulus.
|
ERO1A,
GLRX2,
TRPV2
|
GO:0009267
|
BP
|
cellular response to starvation
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of deprivation of nourishment.
|
FADS1,
ALB,
INHBB,
RALB,
SRD5A1,
SREBF1,
AKR1C3,
DSC2,
SREBF2,
FOXO1,
KLF10,
BMPR2,
GAS6,
CARTPT,
PDK4,
KIAA1324,
SFRP1,
PCSK9,
FBXO22,
FNIP1,
WNT2B,
EHMT2,
ZFYVE1,
RRAGD,
DNAJC15
|
GO:0009268
|
BP
|
response to pH
|
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a pH stimulus. pH is a measure of the acidity or basicity of an aqueous solution.
|
CA2,
ARSB,
GJA1,
PAM,
CLCN7
|
GO:0009298
|
BP
|
GDP-mannose biosynthetic process
|
The chemical reactions and pathways resulting in the formation of GDP-mannose, a substance composed of mannose in glycosidic linkage with guanosine diphosphate.
|
PMM2,
GMPPB
|
GO:0009299
|
BP
|
mRNA transcription
|
The cellular synthesis of messenger RNA (mRNA) from a DNA template.
|
EREG,
DDX5,
HSF1,
PPARD
|
GO:0009301
|
BP
|
snRNA transcription
|
The synthesis of small nuclear RNA (snRNA) from a DNA template.
|
SNAPC3
|
GO:0009303
|
BP
|
rRNA transcription
|
The synthesis of ribosomal RNA (rRNA), any RNA that forms part of the ribosomal structure, from a DNA template.
|
CD3EAP,
NPM3,
ANG,
RNASEK,
GTF3A,
NIFK,
POLR1E,
SPIN1
|
GO:0009306
|
BP
|
protein secretion
|
The controlled release of proteins from a cell.
|
FGG,
SCG2,
PDIA4,
CBLN1,
CANX,
ERP29,
ARL4D,
RAB8B,
NECAB3,
LMF1,
ARFGAP3,
CBLN4,
SEL1L
|
GO:0009308
|
BP
|
amine metabolic process
|
The chemical reactions and pathways involving any organic compound that is weakly basic in character and contains an amino or a substituted amino group, as carried out by individual cells. Amines are called primary, secondary, or tertiary according to whether one, two, or three carbon atoms are attached to the nitrogen atom.
|
AOC2,
CYP1A1,
VCAM1,
AOC3
|
GO:0009311
|
BP
|
oligosaccharide metabolic process
|
The chemical reactions and pathways involving oligosaccharides, molecules with between two and (about) 20 monosaccharide residues connected by glycosidic linkages.
|
ST6GAL1,
ST8SIA6,
MGAT2,
ST3GAL1,
ST3GAL3,
ST3GAL4,
ST3GAL2,
ST8SIA4,
ST6GAL2,
ST6GALNAC5,
ST6GALNAC4,
ST6GALNAC2,
MAN1B1,
ST3GAL6
|
GO:0009312
|
BP
|
oligosaccharide biosynthetic process
|
The chemical reactions and pathways resulting in the formation of oligosaccharides, molecules with between two and (about) 20 monosaccharide residues connected by glycosidic linkages.
|
B3GALT2,
MPDU1,
B4GALT1,
MGAT2,
ST6GALNAC5,
FUT8
|
GO:0009313
|
BP
|
oligosaccharide catabolic process
|
The chemical reactions and pathways resulting in the breakdown of oligosaccharides, molecules with between two and (about) 20 monosaccharide residues connected by glycosidic linkages.
|
MAN2B1,
GM2A,
CTBS,
NEU1,
MAN2B2
|
GO:0009314
|
BP
|
response to radiation
|
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an electromagnetic radiation stimulus. Electromagnetic radiation is a propagating wave in space with electric and magnetic components. These components oscillate at right angles to each other and to the direction of propagation.
|
ANGPT2,
FANCG,
MBD4,
PENK,
COL3A1,
NTRK1,
JUN,
BCL2,
TXN,
KRT13,
JUNB,
JUND,
CDC25A,
CXCL12,
SMC1A,
ZAK,
F11R,
TNFRSF11A
|
GO:0009395
|
BP
|
phospholipid catabolic process
|
The chemical reactions and pathways resulting in the breakdown of phospholipids, any lipid containing phosphoric acid as a mono- or diester.
|
APOA2,
PLCG2,
PLA2G4A,
ENPP2,
NAPEPLD,
ABHD6,
LIPG
|
GO:0009396
|
BP
|
folic acid-containing compound biosynthetic process
|
The chemical reactions and pathways resulting in the formation of folic acid and its derivatives.
|
MTHFD2,
MTHFS,
MTHFD1L,
MTHFD2L
|
GO:0009398
|
BP
|
FMN biosynthetic process
|
The chemical reactions and pathways resulting in the formation of FMN, the oxidized form of flavin mononucleotide (riboflavin 5'-(dihydrogen phosphate)), which acts as a coenzyme for a number of oxidative enzymes including NADH dehydrogenase.
|
RFK
|
GO:0009404
|
BP
|
toxin metabolic process
|
The chemical reactions and pathways involving a toxin, a poisonous compound (typically a protein) that is produced by cells or organisms and that can cause disease when introduced into the body or tissues of an organism.
|
PAM,
CYP1B1,
FMO2,
AS3MT
|
GO:0009405
|
BP
|
pathogenesis
|
The set of specific processes that generate the ability of an organism to cause disease in another.
|
TMEM181
|